ATE112687T1 - Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen. - Google Patents

Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen.

Info

Publication number
ATE112687T1
ATE112687T1 AT89909916T AT89909916T ATE112687T1 AT E112687 T1 ATE112687 T1 AT E112687T1 AT 89909916 T AT89909916 T AT 89909916T AT 89909916 T AT89909916 T AT 89909916T AT E112687 T1 ATE112687 T1 AT E112687T1
Authority
AT
Austria
Prior art keywords
hiv
mutants
missing
envelope protein
hypervariable domains
Prior art date
Application number
AT89909916T
Other languages
English (en)
Inventor
Nancy L Haigwood
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE112687T1 publication Critical patent/ATE112687T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT89909916T 1988-09-13 1989-08-21 Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen. ATE112687T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24394488A 1988-09-13 1988-09-13

Publications (1)

Publication Number Publication Date
ATE112687T1 true ATE112687T1 (de) 1994-10-15

Family

ID=22920746

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89909916T ATE112687T1 (de) 1988-09-13 1989-08-21 Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen.

Country Status (6)

Country Link
US (3) US5814458A (de)
EP (1) EP0434713B1 (de)
AT (1) ATE112687T1 (de)
DE (1) DE68918867T2 (de)
HK (1) HK166495A (de)
WO (1) WO1990002568A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP237A (en) * 1990-05-29 1993-04-29 Cedars Sinai Medical Center Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
WO1994028929A1 (en) 1993-06-07 1994-12-22 Genentech, Inc. Hiv envelope polypeptides
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
NL9400384A (nl) * 1994-03-11 1995-10-02 Smit Victor Retrovirus-vaccins, vaccinatie en immunotherapie tegen retrovirale infecties.
US6585979B1 (en) * 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
FR2777007B1 (fr) * 1998-04-01 2000-05-26 Orstom Mutants de glycoproteines d'enveloppes de retrovirus et leurs applications biologiques
FR2786488B1 (fr) * 1998-11-27 2003-04-25 Orstom Mutants de la gp120 et leurs applications biologiques
US7935805B1 (en) * 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
EP1141314A2 (de) 1998-12-31 2001-10-10 Chiron Corporation Für antigene polypeptide des hiv type c kodierende polynukleotide, entsprechende polypeptide und verwendungen davon
ATE384795T1 (de) 1998-12-31 2008-02-15 Novartis Vaccines & Diagnostic Modifizierte hiv env polypeptide
AU2221600A (en) 1998-12-31 2000-07-31 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
CN1423698A (zh) 1999-11-16 2003-06-11 真那特应用生物科技有限公司 Hiv－1亚型间(c/b’)基因组和其用途
AU2002305914A1 (en) 2001-01-12 2002-10-21 Chiron Corporation Nucleic acid mucosal immunization
RU2221873C2 (ru) * 2001-04-24 2004-01-20 Закрытое акционерное общество "АСГЛ-Фармацевтические Инновации" Способ получения каталитических антител (варианты), антигены для иммунизации и нуклеотидная последовательность
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP1409694A4 (de) 2001-07-05 2006-02-08 Chiron Corp Antigene typ-b- und/oder typ-c-hiv-polypeptide codierende polynukleotide, polypeptide und deren verwendungen
CA2458995C (en) 2001-08-31 2013-04-30 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
AU2003300870A1 (en) * 2002-12-11 2004-06-30 The Scripps Research Institute Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same
US20040247586A1 (en) * 2003-03-05 2004-12-09 Asa Abeliovich Parkin-associated complex for protecting post-mitotic neurons from excitotoxicity and uses thereof
EP1628680B1 (de) * 2003-05-15 2012-10-24 Novartis Vaccines and Diagnostics, Inc. Hiv polynucleotide und polypeptide von botswana mj4
WO2006050394A2 (en) 2004-11-01 2006-05-11 Novartis Vaccines And Diagnostics Inc. Combination approaches for generating immune responses
EP1945247A1 (de) 2005-10-18 2008-07-23 Novartis Vaccines and Diagnostics, Inc. Mukosale und systemische immunisierungen mit alphavirus-replicon-teilchen
CA2648086C (en) * 2006-03-29 2014-05-13 Dana Farber Cancer Institute, Inc. Methods and compositions for inducing an immune response to hiv and models for testing
EP2019686B1 (de) 2006-03-31 2012-07-11 Novartis AG Kombinierte mukosale und parenterale immunisierung gegen hiv
WO2008039983A2 (en) * 2006-09-28 2008-04-03 President And Fellows Of Harvard College Methods and compositions using mutant gp120
US8278418B2 (en) 2008-09-26 2012-10-02 Ambrx, Inc. Modified animal erythropoietin polypeptides and their uses
MX2014005548A (es) 2011-11-14 2014-08-21 Novartis Ag Complejos inmunogenicos de carbomeros polianionicos y polipeptidos env y metodos de manufactura y usos de los mismos.
US11318197B2 (en) 2016-03-03 2022-05-03 Duke University Compositions and methods for inducing HIV-1 antibodies
CA3016352A1 (en) 2016-03-03 2017-09-08 Duke University Compositions and methods for inducing hiv-1 antibodies
EP3519428A4 (de) 2016-10-03 2020-07-08 Duke University Verfahren zur identifizierung von immunogenen durch targeting unwahrscheinlicher mutationen
TW201922138A (zh) 2017-10-17 2019-06-16 英商Ｈｄ３有限公司 頭髮造型裝置、頭髮造型方法及驅動系統
US11963596B2 (en) 2018-06-15 2024-04-23 Japham Group Limited Hair styling device
US12138304B2 (en) 2018-10-01 2024-11-12 Duke University HIV-1 envelope stabilizing mutations
GB201902443D0 (en) 2019-02-22 2019-04-10 Hd3 Ltd Hair styling device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341482C (en) * 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
EP0242216A1 (de) * 1986-04-16 1987-10-21 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Nicht cytopathischer Klon von menschlichem T-Zellen lymphotropen Virus Typ-III
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome

Also Published As

Publication number Publication date
US5817792A (en) 1998-10-06
HK166495A (en) 1995-11-03
US5792459A (en) 1998-08-11
DE68918867D1 (de) 1994-11-17
US5814458A (en) 1998-09-29
WO1990002568A1 (en) 1990-03-22
DE68918867T2 (de) 1995-02-16
EP0434713B1 (de) 1994-10-12
EP0434713A4 (en) 1992-05-20
EP0434713A1 (de) 1991-07-03

Similar Documents

Publication Publication Date Title
DE68918867D1 (de) Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen.
DK371087D0 (da) Mamalialt interleukin-4
UA41888C2 (uk) Злитий білок, який складається з мишачого або олюдненого моноклонального антитіла мав425 або його фрагменту, який спрямовано проти пухлинної клітини, спосіб його отримання, фармацевтична композиція
NO973848D0 (no) Fremgangsmåte til fremstilling av hemoglobinliknende protein
ATE125362T1 (de) Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung.
DE3588006D1 (de) Atrielle natriumuretische/gefässerweiterende polypeptide.
EP0431541A3 (en) Toxoplasma gondii antigen, its production and use
ES2059428T3 (es) Metodo para la preparacion de proteinas ajenas en las levaduras, adn recombinante, transformante.
DE69535719D1 (de) Fas-antigenbindender ligand
GB2301363A (en) Human phosphodiesterase type ivc and its production and use
ATE164838T1 (de) Neue propoxyphenderivate sowie deren protein-und polypeptidlabels und-konjugate
KR900012626A (ko) 하이브리드 단백질, 이의 생산방법 및 이를 함유하는 약제학적 조성물
EP0369816A3 (de) Gegen menschliches polymorphes epitheliales Muzin spezifische monoklonale Antikörper
JPS6461499A (en) Monoclonal antibody to human papilloma viruses 16 type e7 protein, and production and use thereof
FI871607L (fi) Menetelmä peptidien valmistamiseksi, menetelmässä käyttökelpoinen yhdistelmäplasmidi ja plasmidilla transformoituja myeloomasoluja
AU1190388A (en) Methods and materials for hiv detection and therapy
ATE103973T1 (de) Gamma-atriales, natriuretisches polypeptid erkennende monoklonale antikoerper, solche antikoerper produzierende hybridome und deren herstellung und verwendung.
ATE153379T1 (de) Expression von proteinsüssmitteln in hefe
ES2059823T3 (es) Metodos y sistemas para producir antigenos de hiv.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time